IACH 5: Bispecific Antibodies Across the Multiple Myeloma Continuum: From High-Risk Smoldering Myeloma to Relapsed Disease
Here is a concise 5-question CME post-activity survey covering knowledge, confidence, intended practice change, barriers, and overall evaluation:
